Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-23

Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether adding AE-941 to combination chemotherapy and radiation improves outcomes for patients with stage III non-small cell lung can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AE-941 (Neovastat) (AE-941)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer | Phase 3 | Status: COMPLETED